BINECT AG (MA10.DE) Fundamental Analysis & Valuation

FRA:MA10 • DE000A3H2135

Current stock price

1.45 EUR
-0.03 (-2.03%)
Last:

This MA10.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. MA10.DE Profitability Analysis

1.1 Basic Checks

  • MA10 had positive earnings in the past year.
  • MA10 had a positive operating cash flow in the past year.
  • MA10 had positive earnings in each of the past 5 years.
  • MA10 had a positive operating cash flow in 4 of the past 5 years.
MA10.DE Yearly Net Income VS EBIT VS OCF VS FCFMA10.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5M -10M

1.2 Ratios

  • MA10's Return On Assets of 0.90% is in line compared to the rest of the industry. MA10 outperforms 51.69% of its industry peers.
  • MA10 has a Return On Equity of 1.33%. This is comparable to the rest of the industry: MA10 outperforms 42.37% of its industry peers.
  • MA10's Return On Invested Capital of 0.25% is in line compared to the rest of the industry. MA10 outperforms 47.46% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MA10 is significantly below the industry average of 8.97%.
Industry RankSector Rank
ROA 0.9%
ROE 1.33%
ROIC 0.25%
ROA(3y)0.77%
ROA(5y)0.93%
ROE(3y)1.14%
ROE(5y)1.28%
ROIC(3y)0.97%
ROIC(5y)1.35%
MA10.DE Yearly ROA, ROE, ROICMA10.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • MA10 has a Profit Margin of 0.54%. This is in the lower half of the industry: MA10 underperforms 60.17% of its industry peers.
  • In the last couple of years the Profit Margin of MA10 has declined.
  • MA10 has a Operating Margin of 0.16%. This is comparable to the rest of the industry: MA10 outperforms 45.76% of its industry peers.
  • In the last couple of years the Operating Margin of MA10 has declined.
  • With a Gross Margin value of 26.88%, MA10 perfoms like the industry average, outperforming 54.24% of the companies in the same industry.
  • MA10's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.16%
PM (TTM) 0.54%
GM 26.88%
OM growth 3Y-60.64%
OM growth 5Y-42.89%
PM growth 3Y-24.15%
PM growth 5Y-35.9%
GM growth 3Y-16.06%
GM growth 5Y-10.45%
MA10.DE Yearly Profit, Operating, Gross MarginsMA10.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MA10.DE Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, MA10 has about the same amount of shares outstanding.
  • Compared to 5 years ago, MA10 has more shares outstanding
  • MA10 has a better debt/assets ratio than last year.
MA10.DE Yearly Shares OutstandingMA10.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M
MA10.DE Yearly Total Debt VS Total AssetsMA10.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

2.2 Solvency

  • An Altman-Z score of 2.73 indicates that MA10 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of MA10 (2.73) is better than 74.58% of its industry peers.
  • A Debt/Equity ratio of 0.04 indicates that MA10 is not too dependend on debt financing.
  • MA10's Debt to Equity ratio of 0.04 is amongst the best of the industry. MA10 outperforms 87.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 2.73
ROIC/WACCN/A
WACCN/A
MA10.DE Yearly LT Debt VS Equity VS FCFMA10.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • MA10 has a Current Ratio of 1.92. This is a normal value and indicates that MA10 is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.92, MA10 is doing good in the industry, outperforming 77.12% of the companies in the same industry.
  • A Quick Ratio of 1.91 indicates that MA10 should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.91, MA10 is doing good in the industry, outperforming 78.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.91
MA10.DE Yearly Current Assets VS Current LiabilitesMA10.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. MA10.DE Growth Analysis

3.1 Past

  • MA10 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.27%, which is quite impressive.
  • The earnings per share for MA10 have been decreasing by -25.43% on average. This is quite bad
  • Looking at the last year, MA10 shows a small growth in Revenue. The Revenue has grown by 5.58% in the last year.
  • The Revenue has been growing by 19.51% on average over the past years. This is quite good.
EPS 1Y (TTM)37.27%
EPS 3Y-7.69%
EPS 5Y-25.43%
EPS Q2Q%-21.04%
Revenue 1Y (TTM)5.58%
Revenue growth 3Y21.04%
Revenue growth 5Y19.51%
Sales Q2Q%-5.34%

3.2 Future

  • Based on estimates for the next years, MA10 will show a very strong growth in Earnings Per Share. The EPS will grow by 36.75% on average per year.
  • The Revenue is expected to grow by 3.72% on average over the next years.
EPS Next Y28.57%
EPS Next 2Y30.93%
EPS Next 3Y36.75%
EPS Next 5YN/A
Revenue Next Year4.59%
Revenue Next 2Y4.92%
Revenue Next 3Y5%
Revenue Next 5Y3.72%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MA10.DE Yearly Revenue VS EstimatesMA10.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5M 10M 15M 20M 25M
MA10.DE Yearly EPS VS EstimatesMA10.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

4

4. MA10.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 36.25, which means the current valuation is very expensive for MA10.
  • The rest of the industry has a similar Price/Earnings ratio as MA10.
  • The average S&P500 Price/Earnings ratio is at 27.42. MA10 is valued slightly more expensive when compared to this.
  • MA10 is valuated correctly with a Price/Forward Earnings ratio of 15.80.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MA10 indicates a somewhat cheap valuation: MA10 is cheaper than 72.88% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.24. MA10 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 36.25
Fwd PE 15.8
MA10.DE Price Earnings VS Forward Price EarningsMA10.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MA10 is valued cheaply inside the industry as 96.61% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.98
MA10.DE Per share dataMA10.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • MA10's earnings are expected to grow with 36.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.27
PEG (5Y)N/A
EPS Next 2Y30.93%
EPS Next 3Y36.75%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MA10.DE Dividend Analysis

5.1 Amount

  • No dividends for MA10!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MA10.DE Fundamentals: All Metrics, Ratios and Statistics

BINECT AG

FRA:MA10 (4/23/2026, 7:00:00 PM)

1.45

-0.03 (-2.03%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.67M
Revenue(TTM)22.13M
Net Income(TTM)119.70K
Analysts82.86
Price Target4.03 (177.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 36.25
Fwd PE 15.8
P/S 0.21
P/FCF N/A
P/OCF 20.24
P/B 0.52
P/tB 1.52
EV/EBITDA 3.98
EPS(TTM)0.04
EY2.76%
EPS(NY)0.09
Fwd EY6.33%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.07
OCFY4.94%
SpS6.87
BVpS2.79
TBVpS0.95
PEG (NY)1.27
PEG (5Y)N/A
Graham Number1.5847 (9.29%)
Profitability
Industry RankSector Rank
ROA 0.9%
ROE 1.33%
ROCE 0.35%
ROIC 0.25%
ROICexc 0.32%
ROICexgc 1.42%
OM 0.16%
PM (TTM) 0.54%
GM 26.88%
FCFM N/A
ROA(3y)0.77%
ROA(5y)0.93%
ROE(3y)1.14%
ROE(5y)1.28%
ROIC(3y)0.97%
ROIC(5y)1.35%
ROICexc(3y)1.26%
ROICexc(5y)1.78%
ROICexgc(3y)7.81%
ROICexgc(5y)9.59%
ROCE(3y)1.38%
ROCE(5y)1.92%
ROICexgc growth 3Y-54.66%
ROICexgc growth 5Y-51.29%
ROICexc growth 3Y-53.35%
ROICexc growth 5Y-36.45%
OM growth 3Y-60.64%
OM growth 5Y-42.89%
PM growth 3Y-24.15%
PM growth 5Y-35.9%
GM growth 3Y-16.06%
GM growth 5Y-10.45%
F-Score7
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 0.49
Cap/Depr 35.92%
Cap/Sales 1.19%
Interest Coverage 1.89
Cash Conversion 30.07%
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.91
Altman-Z 2.73
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)102.82%
Cap/Depr(5y)127.36%
Cap/Sales(3y)3.48%
Cap/Sales(5y)4.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.27%
EPS 3Y-7.69%
EPS 5Y-25.43%
EPS Q2Q%-21.04%
EPS Next Y28.57%
EPS Next 2Y30.93%
EPS Next 3Y36.75%
EPS Next 5YN/A
Revenue 1Y (TTM)5.58%
Revenue growth 3Y21.04%
Revenue growth 5Y19.51%
Sales Q2Q%-5.34%
Revenue Next Year4.59%
Revenue Next 2Y4.92%
Revenue Next 3Y5%
Revenue Next 5Y3.72%
EBIT growth 1Y48.92%
EBIT growth 3Y-52.36%
EBIT growth 5Y-31.75%
EBIT Next Year350%
EBIT Next 3Y79.41%
EBIT Next 5YN/A
FCF growth 1Y-117.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.38%
OCF growth 3Y-45.87%
OCF growth 5Y-23.03%

BINECT AG / MA10.DE Fundamental Analysis FAQ

What is the fundamental rating for MA10 stock?

ChartMill assigns a fundamental rating of 4 / 10 to MA10.DE.


What is the valuation status for MA10 stock?

ChartMill assigns a valuation rating of 4 / 10 to BINECT AG (MA10.DE). This can be considered as Fairly Valued.


What is the profitability of MA10 stock?

BINECT AG (MA10.DE) has a profitability rating of 3 / 10.


How financially healthy is BINECT AG?

The financial health rating of BINECT AG (MA10.DE) is 5 / 10.


Can you provide the expected EPS growth for MA10 stock?

The Earnings per Share (EPS) of BINECT AG (MA10.DE) is expected to grow by 28.57% in the next year.